Menthol 8.3 MG Oral Lozenge — RxCUI 1424614
RxNorm drug concept · Semantic clinical drug
RxCUI 1424614
Semantic clinical drug · SCD
● Current RxNorm concept 13 FDA products
24 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1424614
Official nameMenthol 8.3 MG Oral Lozenge
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped13
Package NDCs mapped24
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Menthol: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Menthol is found in a lot of over-the-counter topical products — creams, gels, patches, sprays, and powders. Depending on the product, it's used to temporarily ease minor muscle an...
- Start with clean, dry skin — free of lotions or creams — before applying the patch. Peel the backing off and press the sticky side firmly to the sore area. Most menthol patches sho...
- Yes, a mild burning or tingling feeling right after applying a menthol product is common and usually settles down within a few days of regular use. What's not normal is severe burn...
- Is that burning sensation after I apply it normal?
🕸️ Concept Web — How Menthol 8.3 MG Oral Lozenge Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Menthol 8.3 MG Oral Lozenge
RxCUI 1424614 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Menthol
6750IN
-
Menthol
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Ricola
701193BN
-
Ricola
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Menthol Oral Lozenge
374544SCDF -
Menthol Lozenge Product
1295113SCDG -
Menthol Oral Product
1159821SCDG -
Menthol Oral Lozenge [Ricola]
701195SBDF -
Ricola Lozenge Product
1296011SBDG -
Ricola Oral Product
1184149SBDG -
Oral Lozenge
316992DF -
Lozenge Product
1294702DFG - +1 more in this family
-
Menthol Oral Lozenge
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Menthol 8.3 MG
1424613SCDC -
Menthol 8.3 MG Oral Lozenge [Ricola]
2599618SBD -
Menthol 8.3 MG [Ricola]
2599617SBDC
-
Menthol 8.3 MG
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Menthol 8.3 MG
SCDC · 1424613 -
Menthol Oral Lozenge
SCDF · 374544 -
Menthol Lozenge Product
SCDG · 1295113 -
Menthol Oral Product
SCDG · 1159821
Brand-Name Concepts
-
Menthol 8.3 MG Oral Lozenge [Ricola]
SBD · 2599618 -
Menthol 8.3 MG [Ricola]
SBDC · 2599617 -
Menthol Oral Lozenge [Ricola]
SBDF · 701195 -
Ricola Lozenge Product
SBDG · 1296011 -
Ricola Oral Product
SBDG · 1184149 -
Ricola
BN · 701193
📦 FDA Products & Package NDCs
13 products · 24 package NDCs
24 package NDCs map to RxCUI 1424614 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 54305-0201-34 | 34 LOZENGE in 1 BAG (54305-201-34) | RICOLA MAX THROAT CARE SWISS CHERRY | Ricola Ag | 2022-03-01 |
| 54305-0202-34 | 34 LOZENGE in 1 BAG (54305-202-34) | RICOLA MAX THROAT CARE COOL PEPPERMINT | Ricola Ag | 2022-03-01 |
| 54305-0203-34 | 34 LOZENGE in 1 BAG (54305-203-34) | RICOLA MAX THROAT CARE HONEY LEMON | Ricola Ag | 2022-03-01 |
| 54305-0313-19 | 19 LOZENGE in 1 BAG (54305-313-19) | DUAL ACTION CHERRY COUGH SUPPRESSANT ORAL ANESTHETIC | Ricola Ag | 2011-04-03 |
| 54305-0313-26 | 26 LOZENGE in 1 BAG (54305-313-26) | DUAL ACTION CHERRY COUGH SUPPRESSANT ORAL ANESTHETIC | Ricola Ag | 2011-04-03 |
| 54305-0313-75 | 175 LOZENGE in 1 BAG (54305-313-75) | DUAL ACTION CHERRY COUGH SUPPRESSANT ORAL ANESTHETIC | Ricola Ag | 2011-04-03 |
| 54305-0323-19 | 19 LOZENGE in 1 BAG (54305-323-19) | DUAL ACTION HONEY LEMON COUGH SUPPRESSANT ORAL ANESTHETIC | Ricola Ag | 2011-04-03 |
| 54305-0323-26 | 26 LOZENGE in 1 BAG (54305-323-26) | DUAL ACTION HONEY LEMON COUGH SUPPRESSANT ORAL ANESTHETIC | Ricola Ag | 2011-04-03 |
| 54305-0323-75 | 175 LOZENGE in 1 BAG (54305-323-75) | DUAL ACTION HONEY LEMON COUGH SUPPRESSANT ORAL ANESTHETIC | Ricola Ag | 2020-01-31 |
| 54305-0617-19 | 19 LOZENGE in 1 BAG (54305-617-19) | EXTRA STRENGTH WITH NATURAL MENTHOL GLACIER MINT COUGH SUPPRESSANT | Ricola Ag | 2013-05-27 |
| 54305-0617-26 | 26 LOZENGE in 1 BAG (54305-617-26) | EXTRA STRENGTH WITH NATURAL MENTHOL GLACIER MINT COUGH SUPPRESSANT | Ricola Ag | 2013-05-27 |
| 63667-0201-34 | 34 LOZENGE in 1 BAG (63667-201-34) | RICOLA MAX THROAT CARE SWISS CHERRY | Ricola USA Inc. | 2022-03-01 |
| 63667-0202-34 | 34 LOZENGE in 1 BAG (63667-202-34) | RICOLA MAX THROAT CARE COOL PEPPERMINT | Ricola USA Inc. | 2022-03-01 |
| 63667-0203-34 | 34 LOZENGE in 1 BAG (63667-203-34) | RICOLA MAX THROAT CARE HONEY LEMON | Ricola USA Inc. | 2022-03-01 |
| 63667-0224-19 | 19 LOZENGE in 1 BAG (63667-224-19) | DUAL ACTION CHERRY COUGH SUPPRESSANT ORAL ANESTHETIC | Ricola USA Inc. | 2011-04-03 |
| 63667-0224-26 | 26 LOZENGE in 1 BAG (63667-224-26) | DUAL ACTION CHERRY COUGH SUPPRESSANT ORAL ANESTHETIC | Ricola USA Inc. | 2011-04-03 |
| 63667-0224-75 | 175 LOZENGE in 1 BAG (63667-224-75) | DUAL ACTION CHERRY COUGH SUPPRESSANT ORAL ANESTHETIC | Ricola USA Inc. | 2011-04-03 |
| 63667-0234-19 | 19 LOZENGE in 1 PACKAGE (63667-234-19) | DUAL ACTION HONEY LEMON COUGH SUPPRESSANT ORAL ANESTHETIC | Ricola USA Inc. | 2015-05-01 |
| 63667-0234-26 | 26 LOZENGE in 1 PACKAGE (63667-234-26) | DUAL ACTION HONEY LEMON COUGH SUPPRESSANT ORAL ANESTHETIC | Ricola USA Inc. | 2015-05-01 |
| 63667-0234-75 | 175 LOZENGE in 1 PACKAGE (63667-234-75) | DUAL ACTION HONEY LEMON COUGH SUPPRESSANT ORAL ANESTHETIC | Ricola USA Inc. | 2020-01-31 |
| 63667-0503-19 | 19 LOZENGE in 1 BAG (63667-503-19) | EXTRA STRENGTH WITH NATURAL MENTHOL GLACIER MINT COUGH SUPPRESSANT | Ricola USA Inc. | 2013-05-27 |
| 63667-0503-26 | 26 LOZENGE in 1 BAG (63667-503-26) | EXTRA STRENGTH WITH NATURAL MENTHOL GLACIER MINT COUGH SUPPRESSANT | Ricola USA Inc. | 2013-05-27 |
| 63667-0603-19 | 19 LOZENGE in 1 BAG (63667-603-19) | DUAL ACTION GLACIER MINT COUGH SUPPRESSANT ORAL ANESTHETIC | Ricola USA Inc. | 2016-01-01 |
| 63667-0603-26 | 26 LOZENGE in 1 BAG (63667-603-26) | DUAL ACTION GLACIER MINT COUGH SUPPRESSANT ORAL ANESTHETIC | Ricola USA Inc. | 2016-01-01 |
Observed labelers:
Ricola USA Inc. (13) ·
Ricola Ag (11)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.